Across TCGA pan-cancer cohorts, RPS3AP10 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS3AP10’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPS3AP10 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS3AP10 is over-expressed in tumor, although a few such as STAD and LUAD show the opposite, repressed pattern.

STAD, LUAD, and LUAD are the cancer types where RPS3AP10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS3AP10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	III,IV	−0.286	.024	1	view →
LUAD	Male	II,III,IV	+0.190	.048	1	view →
LUAD	Female	II,III,IV	−0.096	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPS3AP10 RNA expression & survival · all RPS3AP10 data types